Delivery Order SPE2D021DA002-SPE2D325F316F
Award Date 8/13/25
Potential Completion Date 8/18/25
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for $1,636.62 on April 23, 2025, with a completion date of April 24, 2025. The award covers the supply of Twinrix vaccine syringes under a firm fixed-price delivery order structure. This award was issued without a set-aside designation and represents a draw-down from DMS Pharmaceutical Group's larger indefinite delivery contract vehicle with the...
- The U.S. Defense Logistics Agency (DLA), under its Medical Supply Chain program, awarded a delivery order to DMS Pharmaceutical Group Inc. on August 8, 2025, for the supply of Twinrix vaccine syringes. The contract, valued at $4,091.55 with a firm fixed-price structure, is scheduled for completion by August 13, 2025, and will be fulfilled from the contractor's location in Park Ridge, Illinois. This delivery order was awarded without a set-aside designation, allowing the vendor to compete in...
- The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $8,183.10 to DMS Pharmaceutical Group Inc. on August 1, 2025, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The contract carries no set-aside designation, allowing DMS...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $4,091.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Twinrix vaccine in syringe form. This firm fixed-price delivery order, issued on June 16, 2025, with an ultimate completion date of June 20, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a delivery order to DMS Pharmaceutical Group Inc. for Twinrix vaccine syringes valued at $2,454.93. The award, issued on September 9, 2025, with an ultimate completion date of September 12, 2025, carries firm fixed-price terms under a delivery order contract type with no set-aside designation. Performance will take place at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of Twinrix vaccine in syringe format. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and will be performed at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,813.04 to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Twinrix vaccine syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its headquarters location with an ultimate completion date of September 8, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,636.62 to DMS Pharmaceutical Group Inc. for the supply of TWINRIX vaccine syringes. The award, made on April 30, 2025, with an ultimate completion date of May 1, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is the prime contractor on this...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the TWINRIX vaccine in syringes. The contract, valued at $2,454.93, has a performance period through May 15, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which enables the agency to order a range of pharmaceutical...